Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Monte Rosa Therapeutics (GLUE) Interest & Investment Income: 2023-2025

Historic Interest & Investment Income for Monte Rosa Therapeutics (GLUE) over the last 3 years, with Sep 2025 value amounting to $2.7 million.

  • Monte Rosa Therapeutics' Interest & Investment Income fell 5.05% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.8 million, marking a year-over-year increase of 14.60%. This contributed to the annual value of $10.6 million for FY2024, which is 13.20% up from last year.
  • Monte Rosa Therapeutics' Interest & Investment Income amounted to $2.7 million in Q3 2025, which was down 10.50% from $3.1 million recorded in Q2 2025.
  • Over the past 5 years, Monte Rosa Therapeutics' Interest & Investment Income peaked at $3.4 million during Q1 2025, and registered a low of $2.2 million during Q3 2023.
  • For the 3-year period, Monte Rosa Therapeutics' Interest & Investment Income averaged around $2.7 million, with its median value being $2.6 million (2024).
  • Data for Monte Rosa Therapeutics' Interest & Investment Income shows a peak YoY increase of 40.83% (in 2025) and a maximum YoY decrease of 5.05% (in 2025) over the last 5 years.
  • Quarterly analysis of 3 years shows Monte Rosa Therapeutics' Interest & Investment Income stood at $2.4 million in 2023, then grew by 9.59% to $2.6 million in 2024, then fell by 5.05% to $2.7 million in 2025.
  • Its Interest & Investment Income was $2.7 million in Q3 2025, compared to $3.1 million in Q2 2025 and $3.4 million in Q1 2025.